CurrentHealthPartnersPolicy N/A

Enhanced HSA Preventive Drug List — Coverage Criteria

Defines medications designated as HSA Preventive drugs for members in HSA‑paired high‑deductible plans, explaining these drugs may be purchased for a copay instead of applying to the deductible and listing many product equivalencies used for formulary and dispensing.

Policy Summary

PayerHealthPartners

PolicyEnhanced HSA Preventive Drug List — Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionCheck the member's plan details or contact Member Services to confirm whether the HSA preventive benefit applies and review the Pharmacy Drug List for complete coverage rules.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

HSAdesignation (plan type affected)

partialdocument is a partial extract

20+distinct drug groups visible

30+pen needle / supply mappings

54-73document chunk range

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria

This list provides general information about medications designated as HSA preventive drugs. If there is a difference between this general information and your plan documents, your plan documents will be used to determine your coverage. Members and providers should consult the member's specific plan documents or Member Services for definitive coverage determinations.

The excerpt provided contains product equivalency and cross‑reference mappings for many supply items (pen needles, syringes, lancets, and related SKUs) and does not list any explicit exclusions. These equivalencies are intended to identify interchangeable product descriptions for formulary matching or claims processing.

Product Coding and Equivalencies

Product name list / equivalenciesmixed

GNP CLICKFINE 31G X 5/16" NDL	GNP CLICKFINE 31G X 5/16" NDL
GNP INS SYR 0.3 ML 29GX1/2"	GNP INS SYR 0.3 ML 29GX1/2"
GNP INS SYRINGE 1 ML 28G 1/2"	GNP INS SYRINGE 1 ML 28G 1/2"
GNP INSUL SYR 0.3 ML 31GX5/16"	GNP INSUL SYR 0.3 ML 31GX5/16"
GNP INSUL SYR 0.5 ML 31GX5/16"	GNP INSUL SYR 0.5 ML 31GX5/16"
GNP INSULIN SYR 1 ML 31GX5/16"	GNP INSULIN SYR 1 ML 31GX5/16"
GNP LANCING SYSTEM DEVICE	GNP LANCING SYSTEM DEVICE
GNP PEN NEEDLE 31G 5MM	GNP PEN NEEDLE 31G 5MM
GNP PEN NEEDLE 31G 8MM	GNP PEN NEEDLE 31G 8MM
GNP PEN NEEDLE 32G 4MM	GNP PEN NEEDLE 32G 4MM

1–10 of 42

1/5

Actions for Providers and Pharmacies

Note

Member plan verification

Check member plan details or contact Member Services to confirm whether the member's plan includes the Enhanced HSA Preventive Drug List benefit before assuming HSA preventive coverage.

Members should verify plan-specific HSA preventive benefit eligibility with Member Services or via their plan documents.

Prior Authorization

Prior authorization and coverage rules may apply

Coverage rules may apply and are not fully shown in this list. Some medications listed on the preventive drug list may have coverage rules such as prior authorization or step therapy that must be met before a medication is covered. Providers and pharmacies must check the Pharmacy Drug List (Formulary) and the 'More Details' column for specific coverage rules.

Some medications require prior authorization — the PA rules must be met before HSA preventive coverage applies.
Check the formulary for step therapy or other utilization management requirements.

Note

Product names and equivalencies

This section contains product names and equivalency mappings (brand/gauge/length equivalencies for pen needles, syringes, lancets, and related diabetic supply products). The excerpted content is product mapping information and does not by itself enumerate coverage determinations.

Product name mappings and equivalencies are provided here for reference and formulary mapping; they do not replace the formulary or plan documents.
No documentation requirements or denial triggers are specified in these equivalency listings.

Denial Risk

No explicit prior authorization or denial rules in this section

No explicit prior authorization or denial triggers are stated in these equivalency or mapping excerpts. Where prior authorization is required for a specific medication, the requirement and criteria are maintained on the Pharmacy Drug List (Formulary) and in plan-specific coverage documents.

These chunks list therapeutic and product equivalencies only; they do not specify PA criteria or denial conditions.
For any specific PA criteria or denial risk, consult the formulary and plan policy documents.

Step Therapy

Step therapy

No step therapy requirements are described in these excerpts. Step therapy or other utilization management rules may apply but are not shown here — verify on the Pharmacy Drug List (Formulary).

Absence of step therapy detail in this section does not imply absence of step therapy on the formulary.

Definitions

HSA Preventive medications

DefinitionMedications designated for purchase as preventive drugs under HSA‑qualified high‑deductible plans; brand names are shown in ALL CAPS and generics in lower italics.

Benefit effectWhen your employer offers an HSA‑paired high‑deductible plan, medications on this list may be purchased for a copay rather than applied to the deductible.

Review and precedenceThe preventive drug list is a subset of the HealthPartners formulary, is reviewed periodically, and plan documents govern if there is any conflict.

Formulary equivalency / therapeutic substitution

Meaning of mappingA line in the form 'DRUG A = DRUG B' indicates a formulary equivalency or cross‑reference mapping between products or therapeutic alternatives.

PurposeMappings are used to identify equivalent products for formulary matching and claims processing.

Implication for prescribing/dispensingPharmacies and providers should treat mapped products as interchangeable per the formulary mapping; check plan/formulary rules for coverage details.

equivalency listing

Equivalency mappingAn equivalency listing equates one listed product name/strength to another for purposes of formulary or claims processing (e.g., eq nicotine 2 mg chewing gum, 1 = eq nicotine 2 mg chewing gum).

UsageThese mappings appear repeatedly for nicotine products, supplies, and other items to normalize different product descriptors to a common record.

Processing noteUse the mapped product name when determining coverage or applying quantity limits if the claim description matches any alias in the listing.

needle gauge/length notation

Notation formatPen needle and syringe sizes are shown as gauge x length (for example, 31G x 5/16" indicates gauge 31 and length 5/16 inch).

Examples from listExamples include 'GNP CLICKFINE 31G X 5/16" NDL' and 'KINRAY INS SYR 1 ML 31GX5/16"'.

InterpretationGauge (G) denotes needle thickness; a larger gauge number means a thinner needle; length is given in millimeters or fractional inches (e.g., 4MM or 5/16").

Product equivalency cluster

Cluster definitionA product equivalency cluster is a group of product names and SKUs treated as equivalent for the policy's supply list (e.g., TRUE COMFORT PEN NDL 32GX4MM equated with multiple TRUE COMFORT and TRUE‑COMFRT items).

Intended useClusters standardize many brand/model/size variants so that different descriptions resolve to the same formulary/supply entry.

ExampleTRUE COMFORT PEN NDL 32GX4MM = TRUE COMFORT PRO 1 ML 30G 1/2" = TRUE COMFORT PRO 1ML 31G 5/16" (and many others).

OpenPayer

Enhanced HSA Preventive Drug List — Coverage Criteria

Coverage Criteria

Product Coding and Equivalencies

Actions for Providers and Pharmacies

Background

Definitions

Quantity Limits